SNWV Stock Analysis: Buy, Sell, or Hold?
SNWV - SANUWAVE Health, Inc. Common Stock
$10.63
0.03 (0.28%)
▲
5d:
+39.32%
30d:
-29.56%
90d:
-36.91%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 14, 2026
Get Alerted When SNWV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SNWV shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: SNWV shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.96
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNWV is currently trading at $10.63, which is considered slightly low relative to its 30-day fair value range of $9.17 to $15.42. The stock's valuation (Forward PE: 28.7) is in line with its historical norms (28.7). At these levels, the market is pricing in 0.1% annual earnings growth.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $14.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.00 (+276.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $14.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.00 (+276.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$9.17 -
$15.42
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 276.3% below Wall St target ($40.00)
- BULLISH: Expecting earnings turnaround to 0.1% growth with 3.1% revenue growth
Trading Range Analysis
30-Day Trading Range
$9.17 -
$15.42
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$14.52
Resistance Level
$17.07
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.73
Wall Street Target
$40.00
(+276.3%)
Revenue Growth (YoY)
3.1%
Earnings Growth (YoY)
-99.6%
Profit Margin
37.2%
Valuation Premium vs History
+0.1% premium
PE vs Historical
28.7 vs 28.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.1%
(market-implied from PE analysis)
1-Year Target
$10.64
(+0%)
2-Year Target
$10.65
(+0%)
3-Year Target
$10.66
(+0%)
3-Yr Target (if PE normalizes)
(PE: 29→29)
PE COMPRESSION
$10.65
(+0%)
Earnings growth offset by PE compression
📈
Valuation based on Current Earnings
Trailing PE: 11.04 | Current EPS (TTM): $0.96
Bull Case
$5.83
(-45%)
Analyst growth -50.0%, PE expands to 12.2
Base Case
$5.30
(-50%)
Market implied -50.0%, PE stable at 11.0
Bear Case
$7.21
(-32%)
Severe decline -20.0%, PE contracts to 9.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 06, 2026 2:34 AM ET
Data refreshes hourly during market hours. Next update: 3:34 AM
Data refreshes hourly during market hours. Next update: 3:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNWV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
